Linked Life Data

19821273

Source:http://linkedlifedata.com/resource/pubmed/id/19821273

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2009-10-12
pubmed:abstractText
Aspirin is the most widely studied and prescribed antiplatelet agent for preventing serious vascular events, reducing the odds of such events among high vascular risk patients by about a quarter. Thienopyridine derivatives inhibit platelet activation by a different mechanism and so may be more effective.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1469-493X
pubmed:author
pubmed:issnType
Electronic
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
CD001246
pubmed:meshHeading
pubmed:year
2009
pubmed:articleTitle
Thienopyridine derivatives versus aspirin for preventing stroke and other serious vascular events in high vascular risk patients.
pubmed:affiliation
Division of Clinical Neurosciences, University of Edinburgh, Western General Hospital, Crewe Road, Edinburgh, UK, EH4 2XU.
pubmed:publicationType
Journal Article, Review, Meta-Analysis